Skip to main content
Full access
Communications and Updates
Published Online: 1 July 2013

Key Issues Relevant to the Efficacy of Behavioral Treatment for ADHD

To the Editor: In their recent meta-analysis of nonpharmacological interventions for attention deficit hyperactivity disorder (ADHD), Sonuga-Barke et al. (1) concluded that limited evidence is available for behavioral interventions. We raise a number of key issues for consideration with respect to this conclusion.
Most importantly, ADHD symptoms were the primary outcome measure in this meta-analysis. Across disorders, however, functional impairment is what prompts treatment seeking, and reducing impairment is the desired outcome (2). ADHD symptom reduction does not necessarily equate to improvements in functioning (3); impairment is therefore a far more socially valid outcome than psychiatric symptoms per se. For behavioral interventions, the primary target of treatment has historically been impairment. For example, dysfunctional parent-child interactions as evaluated by blinded observational assessments determine larger effects on ADHD symptoms in parent training studies (4) and predict serious developmental outcomes for children with ADHD (5). ADHD symptoms are therefore by no means considered the only (and certainly not the most clinically important) target of treatment.
Additionally, the behavioral intervention studies included in this meta-analysis constitute only a small fraction of the larger treatment literature (4). Furthermore, combining diverse nonpharmacological interventions into a “behavioral intervention category” may grossly undermine the estimated effects of behavioral interventions. For instance, interventions such as direct child therapy and social skills training have little to no empirical evidence, whereas behavioral parent training and behavioral classroom interventions are well-established treatments (6). The approach taken by Sonuga-Barke et al. is analogous to a meta-analysis of pharmacological treatments for ADHD that combines stimulants, antidepressants, and atypical antipsychotics as a single category of “stimulant medications.”
A key issue highlighted in this article is the need to include active treatment comparison conditions to obtain objective evaluations of treatment outcomes, which we fully support. Unfortunately, the approach taken by the authors often involved evaluating teacher ratings after home interventions, parent ratings after school interventions, or brief laboratory or clinic observations of the child’s ADHD symptoms. Behavioral treatments demonstrate the largest effects in the setting in which they are implemented (6), and blinded assessments of behavior in these settings will likely yield a more valid evaluation of treatment effects.
We hope that this article encourages an investment in more rigorously designed outcome studies, but we have concerns about the potential implications of this meta-analysis despite more than 40 years of solid evidence for the efficacy of behavioral interventions.

References

1.
Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, Sergeant J; European ADHD Guidelines Group: Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 2013; 170:275–289
2.
Becker K, Chorpita BF, Daleiden E: Improvements in symptoms versus functioning: how do our best treatments measure up? Adm Policy Ment Health Ment Health Serv Res 2011; 38:440–458
3.
Epstein JN, Langberg JM, Lichtenstein PK, Altaye MB, Brinkman WN, House K, Stark LJ: Attention-deficit/hyperactivity disorder outcomes for children treated in community-based pediatric settings. Pediatrics 2010; 164:160–165
4.
Fabiano GA, Pelham WE, Coles EK, Gnagy EM, Chronis-Tuscano A, O’Connor BC: A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev 2009; 29:129–140
5.
Chronis AM, Lahey BB, Pelham WE, Williams SH, Baumann BL, Kipp H, Jones HA, Rathouz PJ: Maternal depression and early positive parenting predict future conduct problems in young children with attention-deficit/hyperactivity disorder. Dev Psychol 2007; 43:70–82
6.
Pelham WE, Fabiano GA: Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol 2008; 37:184–214

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 799
PubMed: 23820833

History

Accepted: April 2013
Published online: 1 July 2013
Published in print: July 2013

Authors

Details

Andrea Chronis-Tuscano, Ph.D.
From the Department of Psychology, University of Maryland, College Park; the Department of Psychology, Queens College, City University of New York, Flushing; and the Department of Psychiatry, Medical University of South Carolina, Charleston.
Anil Chacko, Ph.D.
From the Department of Psychology, University of Maryland, College Park; the Department of Psychology, Queens College, City University of New York, Flushing; and the Department of Psychiatry, Medical University of South Carolina, Charleston.
Russell Barkley, Ph.D.
From the Department of Psychology, University of Maryland, College Park; the Department of Psychology, Queens College, City University of New York, Flushing; and the Department of Psychiatry, Medical University of South Carolina, Charleston.

Funding Information

Dr. Chacko has received advisory board fees from Shire Pharmaceutical. Dr. Barkley receives a pension from the State of Massachusetts; book and newsletter royalties from Guilford Press and Jones and Bartlett publishers; Internet course royalties from CMI Education Institute, J&K Seminars, PsychContinuingEd.com, and ContinuingEdCourses.com; and speaking or consulting fees from Eli Lilly and Theravance. Dr. Chronis-Tuscano reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share